直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • 新闻
  • 飞翰事实
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • 慈善性法律援助
  • 管理层
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

Agilent Interference Analysis, PTO’s Lack of Rulemaking Authority Reaffirmed

January 8, 2010

The U.S. Court of Appeals for the Federal Circuit ruled on January 5 that a district court abused its discretion by dismissing a lawsuit challenging several rulings by the Board of Patent Appeals and Interferences. The court reaffirmed its position in the 2009 Agilent case that a Patent and Trademark Office rule on construing patent claims does not apply when evaluating the claims under the “written description” requirement. The case was between Koninklijke Philips Electronics (the assignee of a patent involving a cardiac defibrillator) and Cardiac Science Operating Co. The Board of Patent Appeals and Interferences initially found in favor of Cardiac Science, which had filed an application for priority. Philips then filed suit seeking review of three of its preliminary motions before the board of a claim construction hearing. The judge denied Philips’ motion for a claim construction hearing and sua sponte dismissed the complaint with prejudice. However, on appeal, Judge Arthur Gajarsa agreed with Philips, and not only remanded the case, but also criticized the lower court for failing to give Philips an opportunity to present additional evidence, as is available under a Section 146 appeal. Philips is represented in this matter by Finnegan.

Related Practices

全球知识产权维权、诉讼与审判

联邦巡回法院和最高法院上诉

Related Industries

医疗设备与诊断

Related News

Commentary

State Authority to Regulate Patent ‘Trolls’ at Stake in Longhorn Appeal

November 7, 2025

Press Release

BMW Victory in United States District Court for the Eastern District of Virginia against PTO – In Reexaminations, PTO Director Must State a Ground-By-Ground Basis for a Discretionary EPR Denial

April 7, 2025

Commentary

USPTO Director Kathi Vidal Is Wielding Review Authority to Change Policy on Discretionary Denials

September 23, 2022

Commentary

Vidal Memo Clarifying PTAB Discretionary Denial Analysis Says Fintiv Does Not Apply to Parallel ITC Investigations

June 22, 2022

Commentary

PTO Changes to Follow Supreme Court’s Arthrex Ruling, Attorneys Predict

June 30, 2021

Commentary

Lack of Supervision Over PTAB Judges Runs Afoul of Appointments Clause

June 21, 2021

Commentary

PTO to Create Formal Rules for Starting Patent Validity Trials

October 19, 2020

Commentary

PTAB Precedential Decision Nomination Form Could Lead to More Controversial Decision-Making Outside of Informal Rulemaking

October 15, 2020

Commentary

5 Questions from Tuesday's Cert Grant on PTO Judge Appointments

October 13, 2020

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP